UPDATED May 12, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
6446 | NT$319.00 | 1.3% | -4.8% | NT$103.7b | NT$417.25 | PS20.7x | E109.0% | n/a | Pharmaceuticals & Biotech | ||
1795 | NT$277.00 | -7.7% | 0.5% | NT$76.0b | NT$390.20 | PE18.6x | E25.7% | 1.2% | Pharmaceuticals & Biotech | ||
6472 | NT$707.00 | -4.7% | 17.4% | NT$71.9b | NT$865.00 | PE23.5x | E22.9% | 1.7% | Pharmaceuticals & Biotech | ||
4743 | NT$153.00 | -4.1% | -21.2% | NT$69.5b | NT$262.00 | PS801.1x | E46.9% | 0.06% | Pharmaceuticals & Biotech | ||
6919 | NT$379.00 | -0.3% | 163.2% | NT$52.8b | n/a | PS1357.2x | n/a | n/a | Pharmaceuticals & Biotech | ||
6550 | NT$70.60 | 1.1% | -24.6% | NT$52.1b | n/a | PS14988.2x | n/a | n/a | Pharmaceuticals & Biotech | ||
6491 | NT$502.00 | 1.3% | 42.4% | NT$38.5b | NT$518.17 | PE21.4x | E17.7% | 2.0% | Healthcare | ||
6535 | NT$189.50 | 10.5% | 312.0% | NT$31.3b | NT$2.28 | PS549.3x | E107.6% | n/a | Pharmaceuticals & Biotech | ||
4123 | NT$45.05 | 3.4% | 1.0% | NT$30.9b | n/a | PS22.2x | n/a | 3.3% | Pharmaceuticals & Biotech | ||
6589 | NT$79.90 | -0.6% | -26.4% | NT$24.5b | NT$132.50 | PS23.9x | E120.0% | n/a | Pharmaceuticals & Biotech | ||
4147 | NT$86.50 | -1.7% | -18.8% | NT$23.6b | NT$133.69 | PS48x | E97.0% | n/a | Pharmaceuticals & Biotech | ||
3218 | NT$259.00 | 3.2% | -28.4% | NT$21.9b | NT$298.75 | PE20.3x | S10.4% | 2.7% | Healthcare | ||
1789 | NT$27.60 | -2.5% | 6.6% | NT$21.8b | NT$26.00 | PE56.7x | n/a | 1.1% | Pharmaceuticals & Biotech | ||
6617 | NT$187.50 | 3.3% | -35.8% | NT$21.3b | n/a | PS1123.5x | n/a | n/a | Pharmaceuticals & Biotech | ||
6620 | NT$139.00 | 14.9% | -16.3% | NT$19.6b | NT$200.00 | PE27x | n/a | 0.7% | Pharmaceuticals & Biotech | ||
4105 | NT$78.40 | 1.0% | 4.0% | NT$19.5b | NT$86.50 | PE16.7x | E19.8% | 4.5% | Pharmaceuticals & Biotech | ||
6547 | NT$54.10 | 0.9% | -7.5% | NT$17.8b | n/a | PS45.6x | n/a | n/a | Pharmaceuticals & Biotech | ||
6785 | NT$252.00 | -5.4% | 40.8% | NT$16.8b | n/a | PE40.9x | n/a | 0.6% | Pharmaceuticals & Biotech | ||
6976 | NT$28.50 | -0.5% | n/a | NT$16.2b | n/a | PS978.4x | n/a | n/a | Pharmaceuticals & Biotech | ||
4771 | NT$299.00 | -6.0% | 80.1% | NT$15.9b | NT$407.00 | PE27.9x | n/a | 1.2% | Healthcare | ||
4736 | NT$163.00 | 3.2% | -9.2% | NT$15.5b | NT$161.00 | PE15.3x | E3.2% | 12.3% | Healthcare | ||
6782 | NT$233.50 | -5.5% | 6.9% | NT$15.3b | NT$301.33 | PE48.8x | E45.6% | 1.0% | Healthcare | ||
4114 | NT$39.55 | 1.2% | -2.0% | NT$15.1b | n/a | PE25.4x | n/a | 1.5% | Pharmaceuticals & Biotech | ||
6712 | NT$200.50 | -2.9% | -2.4% | NT$14.7b | n/a | PE27.3x | n/a | 1.7% | Pharmaceuticals & Biotech |